ECONOMIC EVALUATION AND BUDGET IMPACT OF FULVESTRANT (FASLODEX®) IN THE TREATMENT OF LOCALLY ADVANCED OR METASTATIC BREAST CANCER IN POSTMENOPAUSAL WOMEN WHO HAVE NOT RECEIVED PRIOR ENDOCRINE THERAPY FROM THE PERSPECTIVE OF THE PUBLIC HEALTHCARE SYSTEM IN MEXICO

被引：0

作者：

Carlos, F. ^{[1
]}

Guzman, J. ^{[2
]}

Naranjo, M. ^{[3
]}

Carmona, M. ^{[3
]}

机构：

[1] RAC Salud Consultores SA CV, Mexico City, DF, Mexico

[2] AHS Hlth Consulting SA CV, Mexico City, DF, Mexico

[3] AstraZeneca, Mexico City, DF, Mexico

来源：

关键词：

D O I：

10.1016/j.jval.2019.04.256

中图分类号：

F [经济];

学科分类号：

02 ;

摘要：

PCN132

引用

页码：S81 / S81

页数：1